Clinical Trials Browser

Not yet recruiting × Ovarian Neoplasms × dalpiciclib × Clear all

NCT06552858 2024-08-14

Fluzoparib Combined With Dalpiciclib for Platinum Resistant Recurrent Ovarian Cancer

Phase 2 Not yet recruiting

Ovarian Neoplasms